Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticoagulation in Patients Suffering From COVID-19 Disease-The Anti-Co Trial

NCT04445935 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04445935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticoagulation in Patients Suffering From COVID-19 Disease-The Anti-Co Trial
Lead sponsor
Hamad Medical Corporation
Phase
Phase 4
Overall status
Unknown status
Start date
June 28, 2020
Completion date
March 28, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulation in covid-19 ards